Manulife (Manufacturers Life Insurance)
TARS icon

Manulife (Manufacturers Life Insurance)’s Tarsus Pharmaceuticals TARS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
38,198
+794
+2% +$50.7K ﹤0.01% 1501
2026
Q1 		$2.62M Sell
37,404
-17,879
-32% -$1.25M ﹤0.01% 1390
2025
Q4 		$4.54M Buy
55,283
+1,284
+2% +$95.9K ﹤0.01% 1200
2025
Q3 		$3.21M Buy
53,999
+971
+2% +$47.8K ﹤0.01% 1345
2025
Q2 		$2.15M Sell
53,028
-2,809
-5% -$126K ﹤0.01% 1470
2025
Q1 		$2.87M Buy
55,837
+9,060
+19% +$448K ﹤0.01% 1356
2024
Q4 		$2.59M Buy
46,777
+13,848
+42% +$629K ﹤0.01% 1454
2024
Q3 		$1.08M Sell
32,929
-353
-1% -$9.92K ﹤0.01% 1888
2024
Q2 		$905K Buy
33,282
+3,112
+10% +$105K ﹤0.01% 1911
2024
Q1 		$1.1M Buy
30,170
+18,836
+166% +$554K ﹤0.01% 1814
2023
Q4 		$230K Buy
+11,334
New +$189K ﹤0.01% 2545

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TARS Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Tarsus Pharmaceuticals (TARS) stake by 2.1% in Q2 2026, buying an estimated $50.7K and bringing the position to 38,198 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Manulife (Manufacturers Life Insurance) first reported a position in TARS in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.54M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 38,198 shares of Tarsus Pharmaceuticals worth $2.4M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 794 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $50.7K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1501 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Tarsus Pharmaceuticals position peaked at $4.54M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.